arrow_left You’re on the news side, go back to data on Novo

Latest news about Novo

11 hours ago

There has been 10 news about Novo in the past from 6 different sources and amongst 2 sections

dataset_white Full dataset

Evolution

Here is the latest:

The Wall Street Journal
Eli Lilly and Novo Want to Shake off Ozempic Copycats. Are They Ready To Meet Demand?
Read link
Nov 17, 2024
The Hill
Novo CEO to blame drug middlemen
Read link
Sep 23, 2024
Bloomberg
Novo's Wegovy Puts a Higher Price on Heart Health in the US
Read link
Sep 20, 2024
Bloomberg
Lilly Gains in Obesity Race With Novo as Supplies Expand
Read link
Aug 08, 2024
CNBC News
Beyond Novo and Eli Lilly: Watch these biotech and weight loss drug names, fund manager says
Read link
Jul 29, 2024
Bloomberg
Novo Won't Meet Wegovy Demand in Short-Medium Term: CFO
Read link
May 02, 2024
Axios
Wegovy maker Novo inks $16.5 billion acquisition of Catalent to boost supply
Read link
Feb 05, 2024
The Wall Street Journal
Why Obesity Drug Coverage Doesn't Matter (Yet) for Lilly and Novo
Read link
Jan 31, 2024
CNBC News
Lilly trades at a premium to Ozempic maker Novo as obesity drugs boom. Here's why, analyst says
Read link
Nov 10, 2023
Reuters
Catalent's Indiana plant to make Novo's Wegovy weight-loss drug
Read link
Aug 25, 2023

Distribution by section

The coverage span across 2 distinct sections:

Distribution by publisher

There has been 6 publishers reporting on this, here are the top ones:

  • Bloomberg (30%)
  • CNBC News (20%)
  • The Wall Street Journal (20%)
  • The Hill (10%)
  • Reuters (10%)

Details

This content can be used under the CC BY 4.0 license